Literature DB >> 1372140

Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein.

F Megret1, J P Hugnot, A Falconar, M K Gentry, D M Morens, J M Murray, J J Schlesinger, P J Wright, P Young, M H Van Regenmortel.   

Abstract

Sixteen overlapping fragments of the dengue-2 virus envelope (E) protein, expressed as trpE-E fusion products in Escherichia coli, were used to map the epitopes defined by a panel of 20 monoclonal antibodies (MAbs) by immunoblotting. Using this technique, the amino acid sequence of six antigenic domains on the E protein was characterized. Nonneutralizing MAbs were found to define either linear-specific, subcomplex-specific (amino acids 22-58), and complex-specific (amino acids 304-332) epitopes or a subcomplex conformational-dependent epitope requiring the presence of two closely linked amino acid sequences from the E protein, 60-97 and 298-397. Neutralizing MAbs, however, defined either group-reactive epitopes present on two overlapping domains (amino acids 60-135; amino acids 60-205) or type-, subcomplex-, complex-, subgroup-, and group-specific determinants (amino acids 298-397). These neutralizing epitopes were all found to be dependent upon disulfide bridges. Our results suggest that the maintenance of a topographical arrangement of discontinuous antigenic domains in the flavivirus E-protein is necessary to induce neutralizing and protective antibodies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372140     DOI: 10.1016/0042-6822(92)90450-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  35 in total

1.  Replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2.

Authors:  Smita Jaiswal; Navin Khanna; S Swaminathan
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein.

Authors:  Yorgo Modis; Steven Ogata; David Clements; Stephen C Harrison
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Single antigen detects both immunoglobulin M (IgM) and IgG antibodies elicited by all four dengue virus serotypes.

Authors:  Menaka D Hapugoda; Gaurav Batra; W Abeyewickreme; S Swaminathan; N Khanna
Journal:  Clin Vaccine Immunol       Date:  2007-09-26

4.  Protection by immunoglobulin dual-affinity retargeting antibodies against dengue virus.

Authors:  James D Brien; Soila Sukupolvi-Petty; Katherine L Williams; Chia-Ying Kao Lam; Michael A Schmid; Syd Johnson; Eva Harris; Michael S Diamond
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

5.  Analysis of functional epitopes on the dengue 2 envelope (E) protein using monoclonal IgM antibodies.

Authors:  Z Jianmin; M L Linn; R Bulich; M K Gentry; J G Aaskov
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  PrM- and cell-binding domains of the dengue virus E protein.

Authors:  S Wang; R He; R Anderson
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  Identification of B-cell epitope of dengue virus type 1 and its application in diagnosis of patients.

Authors:  H C Wu; Y L Huang; T T Chao; J T Jan; J L Huang; H Y Chiang; C C King; M F Shaio
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

8.  The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.

Authors:  Bimmi Shrestha; James D Brien; Soila Sukupolvi-Petty; S Kyle Austin; Melissa A Edeling; Taekyung Kim; Katie M O'Brien; Christopher A Nelson; Syd Johnson; Daved H Fremont; Michael S Diamond
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

9.  Generation and characterization of monoclonal antibodies against dengue virus type 1 for epitope mapping and serological detection by epitope-based peptide antigens.

Authors:  Yun-Ching Chen; Hsien-Neng Huang; Chin-Tarng Lin; Yi-Fang Chen; Chwan-Chuen King; Han-Chung Wu
Journal:  Clin Vaccine Immunol       Date:  2007-02-07

10.  Monoclonal antibodies that bind to common epitopes on the dengue virus type 2 nonstructural-1 and envelope glycoproteins display weak neutralizing activity and differentiated responses to virulent strains: implications for pathogenesis and vaccines.

Authors:  Andrew K I Falconar
Journal:  Clin Vaccine Immunol       Date:  2007-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.